Cyanotech Corp (CYAN) stock
CYANOTCMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
$0.70+0.00 (0.00%)
Close on Oct 19, 2026Market cap $5.11MP/E –Yield –
Cyanotech ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Cyanotech's ebitda for the twelve months ending Sep 30, 2025 was $381.00K. For fiscal 2025 it was -$1.03M. The highest annual figure on record is $4.17M in fiscal 2022.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | -$1.03M | – |
| FY2024 | Mar 31, 2024 | -$3.00M | – |
| FY2023 | Mar 31, 2023 | -$1.27M | -130.3% |
| FY2022 | Mar 31, 2022 | $4.17M | +127.8% |
| FY2021 | Mar 31, 2021 | $1.83M | -38.7% |
| FY2020 | Mar 31, 2020 | $2.99M | – |
| FY2019 | Mar 31, 2019 | -$1.09M | -133.1% |
| FY2018 | Mar 31, 2018 | $3.29M | +153.9% |
| FY2017 | Mar 31, 2017 | $1.30M | +76.3% |
| FY2016 | Mar 31, 2016 | $735.00K | -53.0% |
| FY2015 | Mar 31, 2015 | $1.57M | +78.7% |
| FY2014 | Mar 31, 2014 | $876.00K | -71.5% |
| FY2013 | Mar 31, 2013 | $3.07M | -14.6% |
| FY2012 | Mar 31, 2012 | $3.60M | +94.9% |
| FY2011 | Mar 31, 2011 | $1.85M | -8.3% |
| FY2010 | Mar 31, 2010 | $2.01M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $536.00K | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$391.00K | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$84.00K | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $320.00K | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$602.00K | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$663.00K | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$1.52M | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$453.00K | -9160.0% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$228.00K | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$802.00K | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$842.00K | -210.6% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $5.00K | -99.5% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$420.00K | -128.4% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$8.00K | -100.8% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $761.00K | +98.7% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $912.00K | – |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $1.48M | +101.9% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $1.02M | +38.6% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $383.00K | -45.6% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -$18.00K | -102.1% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $733.00K | -17.5% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $735.00K | +36.1% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $704.00K | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $854.00K | -11.6% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $889.00K | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $540.00K | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$834.00K | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $966.00K | -38.7% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | -$529.00K | -149.1% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$692.00K | -163.0% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$461.00K | -234.4% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $1.58M | +409.7% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $1.08M | +41.7% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $1.10M | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $343.00K | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $309.00K | -56.8% |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $761.00K | – |
| Q1 FY2017CQ2 2016 | Jun 30, 2016 | -$117.00K | – |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | -$284.00K | – |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | $716.00K | – |
See a number that looks wrong?